{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:43:11Z","timestamp":1781106191289,"version":"3.54.1"},"reference-count":39,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1297\/cpe.26.229","type":"journal-article","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T18:10:05Z","timestamp":1506535805000},"page":"229-241","source":"Crossref","is-referenced-by-count":4,"title":["Incidence of diabetes mellitus and neoplasia in Japanese short-statured children treated with growth hormone in the Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS)"],"prefix":"10.1297","volume":"26","author":[{"given":"Susumu","family":"Yokoya","sequence":"first","affiliation":[{"name":"Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonobu","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Keio University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Ozono","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medicine, Osaka University, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Okayama Saiseikai General Hospital, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Kanzaki","sequence":"additional","affiliation":[{"name":"Division of Pediatrics and Perinatology, Tottori University Faculty of Medicine, Tottori, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Tanaka Growth Clinic, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Chihara","sequence":"additional","affiliation":[{"name":"Hyogo Prefectural Kakogawa Medical Center, Kakogawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jia","sequence":"additional","affiliation":[{"name":"Lilly Research Laboratories, Eli Lilly and Company, Indiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Child","sequence":"additional","affiliation":[{"name":"Lilly Research Laboratories, Eli Lilly and Company, Windlesham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuichiro","family":"Ihara","sequence":"additional","affiliation":[{"name":"Medical Science, Eli Lilly Japan K.K., Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumpei","family":"Funai","sequence":"additional","affiliation":[{"name":"Scientific Communications, Eli Lilly Japan K.K., Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Medical Science, Eli Lilly Japan K.K., Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Seino","sequence":"additional","affiliation":[{"name":"JCHO Osaka Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","unstructured":"1. Tanaka, T. Growth hormone treatment in Japan: past, present, and future. Pediatr Endocrinol Rev 2012;10 (Suppl 1): 89\u201397."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Child, CJ, Zimmermann, AG, Jia, N, Robison, LL, Br\u00e4mswig, JH, Blum, WF. Assessment of primary cancer incidence in growth hormone-treated children: comparison of a multinational prospective observational study with population databases. Horm Res Paediatr 2016;85: 198\u2013206.","DOI":"10.1159\/000444124"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cappa, M, Iughetti, L, Loche, S, Maghnie, M, Vottero, A, GeNeSIS National Board on behalf of the GeNeSIS Italian Investigators. Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study. J Endocrinol Invest 2016;39: 667\u201377.","DOI":"10.1007\/s40618-015-0418-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Luzuriaga Tom\u00e1s, C, Oyarzabal Irigoyen, M, Caveda Cepas, E, V\u00e1zquez Salvi, LA, Garc\u00eda-P\u00e9rez, LE, el grupo de investigadores espa\u00f1oles del estudio GeNeSIS. Safety and efficacy of growth hormone treatment: GeNeSIS study in Spain. An Pediatr (Barc) 2016;84: 139\u201347 (in Spanish).","DOI":"10.1016\/j.anpede.2015.05.025"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. N\u00f8rrelund, H, Vahl, N, Juul, A, M\u00f8ller, N, Alberti, KG, Skakkebaek, NE, et al. Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism. J Clin Endocrinol Metab 2000;85: 1912\u20137.","DOI":"10.1210\/jcem.85.5.6613"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Allen, DB, Backeljauw, P, Bidlingmaier, M, Biller, BM, Boguszewski, M, Burman, P, et al. GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults. Eur J Endocrinol 2016;174: 1\u20139.","DOI":"10.1530\/EJE-15-0873"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. S\u00e4vendahl, L, Pournara, E, Pedersen, BT, Blankenstein, O. Is safety of childhood growth hormone therapy related to dose? Data from a large observational study. Eur J Endocrinol 2016;174: 681\u201391.","DOI":"10.1530\/EJE-15-1017"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Luger, A, Mattsson, AF, Koltowska-H\u00e4ggstr\u00f6m, M, Thunander, M, G\u00f3th, M, Verhelst, J, et al. Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational study. Diabetes Care 2012;35: 57\u201362.","DOI":"10.2337\/dc11-0449"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. M\u00f8ller, N, J\u00f8rgensen, JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 2009;30: 152\u201377.","DOI":"10.1210\/er.2008-0027"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Clayton, PE, Cowell, CT. Safety issues in children and adolescents during growth hormone therapya review. Growth Horm IGF Res 2000;10: 306\u201317.","DOI":"10.1054\/ghir.2000.0175"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Cutfield, WS, Wilton, P, Bennmarker, H, Albertsson-Wikland, K, Chatelain, P, Ranke, MB, et al. Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet 2000;355: 610\u20133.","DOI":"10.1016\/S0140-6736(99)04055-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Child, CJ, Zimmermann, AG, Scott, RS, Cutler, GB, Battelino, T, Blum, WF, GeNeSIS International Advisory Board. Prevalence and incidence of diabetes mellitus in GH-treated children and adolescents: analysis from the GeNeSIS observational research program. J Clin Endocrinol Metab 2011;96: E1025\u201334.","DOI":"10.1210\/jc.2010-3023"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Watanabe, S, Mizuno, S, Oshima, LH, Tsunematsu, Y, Fujimoto, J, Komiyama, A. Leukemia and other malignancies among GH users. J Pediatr Endocrinol Metab 1993;6: 99\u2013108.","DOI":"10.1515\/JPEM.1993.6.1.99"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Renehan, AG, Zwahlen, M, Minder, C, O\u2019Dwyer, ST, Shalet, SM, Egger, M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004;363: 1346\u201353.","DOI":"10.1016\/S0140-6736(04)16044-3"},{"key":"15","first-page":"62","volume":"30","year":"1997","unstructured":"15. Herbold, M. International guidelines on post-authorisation research and surveillance. European Economic Community. Pharmacopsychiatry 1997;30(Suppl): 62\u20134.","journal-title":"Pharmacopsychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0176-3679","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tanaka, T, Hasegawa, T, Ozono, K, Tanaka, H, Kanzaki, S, Yokoya, S, et al. Effect of growth hormone treatment on quality of life in Japanese children with growth hormone deficiency: an analysis from a prospective observational study. Clin Pediatr Endocrinol 2014;23: 83\u201392.","DOI":"10.1297\/cpe.23.83"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Tai, S, Tanaka, T, Hasegawa, T, Ozono, K, Tanaka, H, Kanzaki, S, et al. An observational study of the effectiveness and safety of growth hormone (Humatrope\u00ae) treatment in Japanese children with growth hormone deficiency or Turner syndrome. Endocr J 2013;60: 57\u201364.","DOI":"10.1507\/endocrj.EJ11-0386"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Marshall, WA, Tanner, JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45: 13\u201323.","DOI":"10.1136\/adc.45.239.13"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Marshall, WA, Tanner, JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44: 291\u2013303.","DOI":"10.1136\/adc.44.235.291"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Darendeliler, F, Karagiannis, G, Wilton, P, Ranke, MB, Albertsson-Wikland, K, Anthony Price, D, On Behalf Of The Kigs International Board. Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database). Acta Paediatr 2006;95: 1284\u201390.","DOI":"10.1080\/08035250600577889"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Bakalov, VK, Cooley, MM, Quon, MJ, Luo, ML, Yanovski, JA, Nelson, LM, et al. Impaired insulin secretion in the Turner metabolic syndrome. J Clin Endocrinol Metab 2004;89: 3516\u201320.","DOI":"10.1210\/jc.2004-0122"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Veening, MA, Van Weissenbruch, MM, Delemarre-Van De Waal, HA. Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J Clin Endocrinol Metab 2002;87: 4657\u201361.","DOI":"10.1210\/jc.2001-011940"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Meacham, LR, Sklar, CA, Li, S, Liu, Q, Gimpel, N, Yasui, Y, et al. Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study. Arch Intern Med 2009;169: 1381\u20138.","DOI":"10.1001\/archinternmed.2009.209"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Karaa, A, Goldstein, A. The spectrum of clinical presentation, diagnosis, and management of mitochondrial forms of diabetes. Pediatr Diabetes 2015;16: 1\u20139.","DOI":"10.1111\/pedi.12223"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Woodmansee, WW, Zimmermann, AG, Child, CJ, Rong, Q, Erfurth, EM, Beck-Peccoz, P, et al. GeNeSIS and HypoCCS International Advisory Boards. Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS. Eur J Endocrinol 2013;168: 565\u201373.","DOI":"10.1530\/EJE-12-0967"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Wilton, P, Mattsson, AF, Darendeliler, F. Growth hormone treatment in children is not associated with an increase in the incidence of cancer: experience from KIGS (Pfizer International Growth Database). J Pediatr 2010;157: 265\u201370.","DOI":"10.1016\/j.jpeds.2010.02.028"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Fradkin, JE, Mills, JL, Schonberger, LB, Wysowski, DK, Thomson, R, Durako, SJ, et al. Risk of leukemia after treatment with pituitary growth hormone. JAMA 1993;270: 2829\u201332.","DOI":"10.1001\/jama.270.23.2829"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Nishi, Y, Tanaka, T, Takano, K, Fujieda, K, Igarashi, Y, Hanew, K, et al. Recent status in the occurrence of leukemia in growth hormone-treated patients in Japan. GH Treatment Study Committee of the Foundation for Growth Science, Japan. J Clin Endocrinol Metab 1999;84: 1961\u20135.","DOI":"10.1210\/jcem.84.6.5716"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Bell, J, Parker, KL, Swinford, RD, Hoffman, AR, Maneatis, T, Lippe, B. Long-term safety of recombinant human growth hormone in children. J Clin Endocrinol Metab 2010;95: 167\u201377.","DOI":"10.1210\/jc.2009-0178"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Caturegli, P, Newschaffer, C, Olivi, A, Pomper, MG, Burger, PC, Rose, NR. Autoimmune hypophysitis. Endocr Rev 2005;26: 599\u2013614.","DOI":"10.1210\/er.2004-0011"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Reis, F, Faria, AV, Zanardi, VA, Menezes, JR, Cendes, F, Queiroz, LS. Neuroimaging in pineal tumors. J Neuroimaging 2006;16: 52\u20138.","DOI":"10.1177\/1051228405001514"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Konovalov, AN, Pitskhelauri, DI. Principles of treatment of the pineal region tumors. Surg Neurol 2003;59: 250\u201368.","DOI":"10.1016\/S0090-3019(03)00080-6"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Mootha, SL, Barkovich, AJ, Grumbach, MM, Edwards, MS, Gitelman, SE, Kaplan, SL, et al. Idiopathic hypothalamic diabetes insipidus, pituitary stalk thickening, and the occult intracranial germinoma in children and adolescents. J Clin Endocrinol Metab 1997;82: 1362\u20137.","DOI":"10.1210\/jc.82.5.1362"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Ergun-Longmire, B, Mertens, AC, Mitby, P, Qin, J, Heller, G, Shi, W, et al. Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 2006;91: 3494\u20138.","DOI":"10.1210\/jc.2006-0656"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Sklar, CA, Mertens, AC, Mitby, P, Occhiogrosso, G, Qin, J, Heller, G, et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2002;87: 3136\u201341.","DOI":"10.1210\/jcem.87.7.8606"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Patterson, BC, Chen, Y, Sklar, CA, Neglia, J, Yasui, Y, Mertens, A, et al. Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study. J Clin Endocrinol Metab 2014;99: 2030\u20137.","DOI":"10.1210\/jc.2013-4159"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Liubinas, SV, Munshey, AS, Kaye, AH. Management of recurrent craniopharyngioma. J Clin Neurosci 2011;18: 451\u20137.","DOI":"10.1016\/j.jocn.2010.10.004"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Shen, L, Sun, CM, Li, XT, Liu, CJ, Zhou, YX. Growth hormone therapy and risk of recurrence\/progression in intracranial tumors: a meta-analysis. Neurol Sci 2015;36: 1859\u201367.","DOI":"10.1007\/s10072-015-2269-z"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Gupta, DK, Ojha, BK, Sarkar, C, Mahapatra, AK, Sharma, BS, Mehta, VS. Recurrence in pediatric craniopharyngiomas: analysis of clinical and histological features. Childs Nerv Syst 2006;22: 50\u20135.","DOI":"10.1007\/s00381-005-1171-z"}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/26\/4\/26_2017-0012\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T11:52:46Z","timestamp":1659527566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/26\/4\/26_2017-0012\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.26.229","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}